Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

DMOG (GMP)

DMOG (GMP) is the GMP level of DMOG (HY-15893) . GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. DMOG (GMP) is a HIF-1α stabilizer. DMOG (GMP) promotes the osteogenic, angiogenic, and chondrogenic differentiation of stem cells by stabilizing the expression of HIF-1α. DMOG (GMP) can enhance the osteogenic and angiogenic differentiation potential of stem cells, thereby improving bone regeneration in bone defects. DMOG (GMP) can be used in the research of bone defect repair, vascularized bone regeneration, and the treatment of bone-related diseases (such as osteoporosis and femoral head necrosis) [1].

Product Specifications

CAS Number

[89464-63-1]

Product Name Alternative

Dimethyloxallyl Glycine (GMP)

UNSPSC

12352211

Hazard Statement

H302

Target

Autophagy; HIF/HIF Prolyl-Hydroxylase

Related Pathways

Autophagy; Metabolic Enzyme/Protease

Applications

Neuroscience-Neuromodulation

Field of Research

Cardiovascular Disease

Smiles

O=C(OC)CNC(C(OC)=O)=O

Molecular Formula

C6H9NO5

Molecular Weight

175.14

Precautions

P264-P270-P330-P501

References & Citations

[1]Singh A, et al. Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors induce autophagy and have a protective effect in an in-vitro ischaemia model.Sci Rep. 2020 Jan 31;10 (1) :1597.|[2]Milkiewicz M, et al. Inhibition of endogenous HIF inactivation induces angiogenesis in ischaemic skeletal muscles of mice. J Physiol. 2004 Oct 1;560 (Pt 1) :21-6.|[3]Baader E, et al. Inhibition of prolyl 4-hydroxylase by oxalyl amino acid derivatives in vitro, in isolated microsomes and in embryonic chicken tissues. Biochem J. 1994 Jun 1;300 (Pt 2) :525-30.|[4]Li X, et al. Up-regulation of hypoxia-inducible factor-1α enhanced the cardioprotective effects of ischemic postconditioning in hyperlipidemic rats. Acta Biochim Biophys Sin (Shanghai) . 2014 Feb;46 (2) :112-8.|[5]Schultz K, et al. Prolyl hydroxylase 2 deficiency limits proliferation of vascular smooth muscle cells by hypoxia-inducible factor-1{alpha}-dependent mechanisms. Am J Physiol Lung Cell Mol Physiol. 2009 Jun;296 (6) :L921-7.

Shipping Conditions

Room temperature

Scientific Category

GMP Small Molecules

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

ADAMTS4 (NM_005099) Human Tagged ORF Clone
RC209226 10 µg

ADAMTS4 (NM_005099) Human Tagged ORF Clone

Ask
View Details
BIRC7 Antibody (C-term)
MBS9202462-01 0.08 mL

BIRC7 Antibody (C-term)

Ask
View Details
BIRC7 Antibody (C-term)
MBS9202462-02 0.4 mL

BIRC7 Antibody (C-term)

Ask
View Details
BIRC7 Antibody (C-term)
MBS9202462-03 5x 0.4 mL

BIRC7 Antibody (C-term)

Ask
View Details
C2orf60 antibody
MBS5300259-01 0.1 mL

C2orf60 antibody

Ask
View Details
C2orf60 antibody
MBS5300259-02 5x 0.1 mL

C2orf60 antibody

Ask
View Details